A citation-based method for searching scientific literature

Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog, Sue Healey, Douglas F Easton, Olga Sinilnikova, Javier Benítez, María J García, Susan Neuhausen, Mitchell H Gail, Patricia Hartge, Susan Peock, Debra Frost, D Gareth Evans, Rosalind Eeles, Andrew K Godwin, Mary B Daly, Ava Kwong, Edmond S K Ma, Conxi Lázaro, Ignacio Blanco, Marco Montagna, Emma D'Andrea, Maria Ornella Nicoletto, Sharon E Johnatty, Susanne Krüger Kjær, Allan Jensen, Estrid Høgdall, Ellen L Goode, Brooke L Fridley, Jennifer T Loud, Mark H Greene, Phuong L Mai, Angela Chetrit, Flora Lubin, Galit Hirsh-Yechezkel, Gord Glendon, Irene L Andrulis, Amanda E Toland, Leigha Senter, Martin E Gore, Charlie Gourley, Caroline O Michie, Honglin Song, Jonathan Tyrer, Alice S Whittemore, Valerie McGuire, Weiva Sieh, Ulf Kristoffersson, Håkan Olsson, Åke Borg, Douglas A Levine, Linda Steele, Mary S Beattie, Salina Chan, Robert L Nussbaum, Kirsten B Moysich, Jenny Gross, Ilana Cass, Christine Walsh, Andrew J Li, Ronald Leuchter, Ora Gordon, Montserrat Garcia-Closas, Simon A Gayther, Stephen J Chanock, Antonis C Antoniou, Paul D P Pharoah. JAMA 2012
Times Cited: 361



Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart, Michael Friedlander, Stephen Fox, David Bowtell, Gillian Mitchell. J Clin Oncol 2012
Times Cited: 665




List of shared articles



Times cited

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
21

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers.
Arsen Arakelyan, Ani Melkonyan, Siras Hakobyan, Uljana Boyarskih, Arman Simonyan, Lilit Nersisyan, Maria Nikoghosyan, Maxim Filipenko, Hans Binder. Int J Mol Sci 2021
0

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.
Sook-Yee Yoon, Siu Wan Wong, Joanna Lim, Syuhada Ahmad, Shivaani Mariapun, Heamanthaa Padmanabhan, Nur Tiara Hassan, Shao Yan Lau, Gaik-Siew Ch'ng, Muzhirah Haniffa,[...]. J Med Genet 2021
0

Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?
Ionut-Gabriel Funingana, Marika A V Reinius, Angelica Petrillo, Joo Ern Ang, James D Brenton. Semin Cancer Biol 2021
0

The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study.
Angela Toss, Claudia Piombino, Elena Tenedini, Alessandra Bologna, Elisa Gasparini, Vittoria Tarantino, Maria Elisabetta Filieri, Luca Cottafavi, Filippo Giovanardi, Stefano Madrigali,[...]. Diagnostics (Basel) 2021
0

Tumour Versus Germline BRCA Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom.
Iolia Akaev, Siavash Rahimi, Olubukola Onifade, Francis John Edward Gardner, David Castells-Rufas, Eleanor Jones, Shyamika Acharige, Chit Cheng Yeoh. Diagnostics (Basel) 2021
0

The Potential Predictors in Chemotherapy Sensitivity.
Eun-Kyu Kim, Hee-Chul Shin. Adv Exp Med Biol 2021
0

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
Hee-Sung Ahn, Jung Yoon Ho, Jiyoung Yu, Jeonghun Yeom, Sanha Lee, Soo Young Hur, Yuyeon Jung, Kyunggon Kim, Youn Jin Choi. Cancers (Basel) 2021
0

Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.
Sudeep Gupta, Senthil Rajappa, Suresh Advani, Amit Agarwal, Shyam Aggarwal, Chanchal Goswami, Satya Dattatreya Palanki, Devavrat Arya, Shekhar Patil, Rohit Kodagali. JCO Glob Oncol 2021
1

Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients.
Saya Nagasawa, Kazuhiro Ikeda, Kuniko Horie-Inoue, Sho Sato, Satoru Takeda, Kosei Hasegawa, Satoshi Inoue. Endocr J 2020
1

Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Cécile Le Page, Kurosh Rahimi, Manuel Rodrigues, Viola Heinzelmann-Schwarz, Neil Recio, Stefania Tommasi, Guillaume Bataillon, Lise Portelance, Lisa Golmard, Liliane Meunier,[...]. Gynecol Oncol 2020
6

Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients.
Xianqi Gao, Xiyan Nan, Yilan Liu, Rui Liu, Wanchun Zang, Guangyu Shan, Fei Gai, Jingfeng Zhang, Lei Li, Gang Cheng,[...]. Hum Mutat 2020
7

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
44

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
Fengping Shao, Jun Liu, Yaoyun Duan, Li Li, Liqun Liu, Cai Zhang, Shanyang He. Biosci Rep 2020
6

Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020
4

Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond.
Stergios Boussios, Charlotte Abson, Michele Moschetta, Elie Rassy, Afroditi Karathanasi, Tahir Bhat, Faisal Ghumman, Matin Sheriff, Nicholas Pavlidis. Drugs R D 2020
30

Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer.
Talia Golan, Alex Barenboim, Guy Lahat, Ido Nachmany, Yacov Goykhman, Einat Shacham-Shmueli, Naama Halpern, Eli Brazowski, Ravit Geva, Ido Wolf,[...]. Ann Surg Oncol 2020
13

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean- Christophe Tille,[...]. Sci Rep 2020
11

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome.
Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova, Pavel Vodicka. Cancers (Basel) 2020
6


Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers.
Cécile Le Page, Setor Amuzu, Kurosh Rahimi, Walter Gotlieb, Jiannis Ragoussis, Patricia N Tonin. Semin Cancer Biol 2020
6

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer.
Roshni D Kalachand, Ciaran O'Riain, Sinead Toomey, Aoife Carr, Kirsten M Timms, Sharon O'Toole, Stephen Madden, Mark Bates, John J O'Leary, Noreen Gleeson,[...]. Obstet Gynecol Sci 2020
0

Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.
Michelle R Jones, Pei-Chen Peng, Simon G Coetzee, Jonathan Tyrer, Alberto Luiz P Reyes, Rosario I Corona, Brian Davis, Stephanie Chen, Felipe Dezem, Ji-Heui Seo,[...]. Am J Hum Genet 2020
3

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
Marina Pavanello, Isaac Hy Chan, Amir Ariff, Paul Dp Pharoah, Simon A Gayther, Susan J Ramus. Cancers (Basel) 2020
3

Genomic profiling of platinum-resistant ovarian cancer: The road into druggable targets.
Alexandre André Balieiro Anastácio da Costa, Glauco Baiocchi. Semin Cancer Biol 2020
7

Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.
Ignacio Romero, Susanna Leskelä, Belén Pérez Mies, Andrés Poveda Velasco, José Palacios. EJC Suppl 2020
3

Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia.
Ana Krivokuca, Ivana Boljevic, Stevo Jovandic, Zvonko Magic, Aljosa Mandic, Zorica Tomasevic, Mirjana Brankovic-Magic. J Hum Genet 2019
8

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Helene Schlecht, Emma R Woodward, Fiona I Lallo,[...]. J Med Genet 2019
10

BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists.
Ava Kwong, Ka-Leung Danny Cheng, Chan-Chee Victor Hsue, Sze-Ki Hui, Ching-Yu Roland Leung, Kwong-Chuen Angus Leung, Kai-Cheong Roger Ngan, Sung Inda Soong. Asia Pac J Clin Oncol 2019
0


Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma.
Andreja Gornjec, Srdjan Novakovic, Vida Stegel, Marko Hocevar, Ziva Pohar Marinsek, Barbara Gazic, Mateja Krajc, Erik Skof. BMC Cancer 2019
8

Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
Alexandre A B A da Costa, Luisa M do Canto, Simon Jonas Larsen, Adriana Regina Gonçalves Ribeiro, Carlos Eduardo Stecca, Annabeth Høgh Petersen, Mads M Aagaard, Louise de Brot, Jan Baumbach, Glauco Baiocchi,[...]. BMC Cancer 2019
4

Going to extremes: determinants of extraordinary response and survival in patients with cancer.
Flurina A M Saner, Alan Herschtal, Brad H Nelson, Anna deFazio, Ellen L Goode, Susan J Ramus, Ahwan Pandey, Jessica A Beach, Sian Fereday, Andrew Berchuck,[...]. Nat Rev Cancer 2019
15

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Stefania Gori, Massimo Barberis, Maria Angela Bella, Fiamma Buttitta, Ettore Capoluongo, Paola Carrera, Nicoletta Colombo, Laura Cortesi, Maurizio Genuardi, Massimo Gion,[...]. Crit Rev Oncol Hematol 2019
27